Capital Markets Event: View a recording and access materials presented at OXB’s Capital Markets Event held on 2nd June 2026.

VectorXcellerator: OXB has selected the first programmes to move forward through VectorXcellerator, supporting earlier collaboration in advanced therapies.

OXB launches fast-track offering for AAV and lentiviral vector platforms, accelerating viral vector development and manufacture.

News: OXB honoured at 2025 CDMO Leadership Awards Europe in ‘Cell & Gene Therapy’ category.

Home >> Investors >> Investor calendar

Investor calendar

Event: Half year results for the six months ended 30 June 2026  

Start Date: 22nd Sep, 2026Financial Results

Event: Half Year 2026 Trading update

Date: July/August 2026Financial Results

Event: Full Year 2026 Trading update

Date: February 2027Financial Results

Event: Business update

Date: Q4 2026Financial Results

OXB events

See our planned trade shows, webinars and scientific conferences.

Events
OXB-Who-we-are-intro-832x480px